Rituximab treatment in lupus nephritis – where do we stand?

Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study

(2012) Gabriella Moroni et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits

(2011) T. Jonsdottir et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts

(2011) Cándido Díaz-Lagares et al.   AUTOIMMUNITY REVIEWS

Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis

(2011) C Alejandro Arce-Salinas et al.   RHEUMATOLOGY INTERNATIONAL

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Do Asian patients have worse lupus?

(2010) MY Mok et al.   LUPUS

Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus

(2010) F. Catapano et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts

(2010) T. Jonsdottir et al.   RHEUMATOLOGY

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients

(2009) Tim Y.-T. Lu et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome

(2009) C. Melander et al.   Clinical Journal of the American Society of Nephrology

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study

(2009) John N. Boletis et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids

(2009) R. Pepper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?

(2009) E. K. Li et al.   RHEUMATOLOGY